We have observed a marked increase in NKG2D+iNKT levels in NAFLD patients with higher liver fibrosis, which parallels the results found by Stiglund et al. [51]. The gene discussed is KLRK1; the disease is metabolic dysfunction-associated steatotic liver disease.